JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FIESER, L. F.
Right arrow Articles by SELIGMAN, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FIESER, L. F.
Right arrow Articles by SELIGMAN, A. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 94, Issue 2, 85-96, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


NAPHTHOQUINONE ANTIMALARIALS

XVIII. Metabolic Oxidation Products

LOUIS F. FIESER 1, FREDERIC C. CHANG 1, WILLIAM G. DAUBEN 1, CHARLES HEIDELBERGER 1, HANS HEYMANN 1, and ARNOLD M. SELIGMAN 1

1 Chemical Laboratory, Harvard University, the Surgical Research Laboratory, Beth Israel Hospital, Boston, Department of Surgery, Harvard Medical School

A study of the metabolism of nineteen 2-hydroxy-3-alkyl-1,4-naphthoquinones in human subjects has established that these substances suffer rapid and extensive degradation consisting in oxidation of the hydrocarbon side chain with the production of metabolites that are distinctly more hydrophilic than the compounds administered. Several of the metabolites were isolated and fully identified; they are secondary alcohols, tertiary alcohols, or carboxylic acids.

Submitted on June 7, 1948







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.